Tompkins Financial Corp Purchases 500 Shares of CME Group Inc. (NASDAQ:CME)

Tompkins Financial Corp boosted its position in CME Group Inc. (NASDAQ:CME) by 500.0% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 600 shares of the financial services provider’s stock after buying an additional 500 shares during the period. Tompkins Financial Corp’s holdings in CME Group were worth $132,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC grew its position in CME Group by 21.2% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after buying an additional 8,443 shares in the last quarter. Cetera Investment Advisers increased its position in shares of CME Group by 429.1% in the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after purchasing an additional 38,540 shares during the period. Brookstone Capital Management raised its stake in CME Group by 12.2% in the second quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock valued at $6,156,000 after purchasing an additional 3,325 shares in the last quarter. TD Asset Management Inc lifted its position in CME Group by 16.1% during the first quarter. TD Asset Management Inc now owns 371,849 shares of the financial services provider’s stock worth $80,055,000 after purchasing an additional 51,689 shares during the period. Finally, Epoch Investment Partners Inc. grew its stake in CME Group by 4.7% during the first quarter. Epoch Investment Partners Inc. now owns 99,947 shares of the financial services provider’s stock worth $21,518,000 after buying an additional 4,454 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CME has been the subject of a number of recent analyst reports. Morgan Stanley upped their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Redburn Atlantic lowered CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target on the stock. in a research note on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft upped their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Oppenheimer lifted their target price on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research report on Thursday, October 24th. Finally, The Goldman Sachs Group increased their target price on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $222.73.

Insiders Place Their Bets

In other news, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, insider Sunil Cutinho sold 4,500 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total value of $1,019,880.00. Following the transaction, the insider now owns 27,053 shares in the company, valued at approximately $6,131,291.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martin J. Gepsman sold 400 shares of the firm’s stock in a transaction on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the sale, the director now directly owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,621 shares of company stock valued at $3,441,063. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of CME opened at $225.66 on Friday. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The business has a 50-day moving average of $221.72 and a 200-day moving average of $209.91. The company has a market capitalization of $81.26 billion, a price-to-earnings ratio of 23.73, a price-to-earnings-growth ratio of 5.56 and a beta of 0.55.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.25 earnings per share. As a group, equities research analysts anticipate that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.04%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is currently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.